findmyKOL
Clinical trialNCT00580970CompletedPhase 2Interventional

Study of Effectiveness of Lovastatin to Prevent Radiation-Induced Rectal Injury

SponsorVirginia Commonwealth UniversityEnrollment73Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Lovastatin may protect against late effects of radiation therapy in patients with prostate cancer
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Hunter Holmes Mcguire Veterans Administration Medical Center

    Richmond, Virginia, United States

  • Massey Cancer Center/virginia Commonwealth University

    Richmond, Virginia, United States

  • Southside Regional Medical Center

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Lovastatin →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2007
Primary completion
31 Aug 2015
Completion
31 Aug 2015
Last update posted
18 Nov 2016
Registered enrollment
73
Registry id
NCT00580970
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.